Aiming for tighter blood sugar control is among the recommendations in a suite of updated guidelines from NICE to improve management of diabetes in children and adults.
25 August 2015
The best way to diagnose, treat and monitor myeloma – a type of incurable blood cancer – has been set out in draft guidance by the National Institute for Health and Care Excellence (NICE).
18 August 2015
The right antibiotic, at the right dose at the right time should be given to patients, to avoid the serious threat of antibiotic-resistant infections, according to new NICE guidance
17 August 2015
The needs of local communities should be at the heart of local initiatives to improve health and wellbeing, the National Institute for Health and Care Excellence (NICE) has said.
11 August 2015
In draft guidance published today NICE has recommended the anti-blood clotting drug edoxaban (Lixiana, Daiichi Sankyo) as an option for preventing stroke and systemic embolism (blood clots) in adults with non-valvular atrial fibrillation (NVAF) who have one or more further risk factors.
06 August 2015
NICE has today (Thursday 6 August) opened a second consultation on preliminary draft guidance on the drug olaparib (Lynparza) for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube and peritoneal cancer. The drug is for cancers in people who have tested positive for the BRCA1 or BRCA2 mutations, and whose disease has responded to platinum-based chemotherapy.
06 August 2015
0300 323 0142
(this number rings all our phones and is the best number to contact us on 9:00 – 17:30 Mon - Fri)
(out of office hours number)
Press releases are usually issued under embargo on the day before they are published on the website. If you are a journalist and would like to be added to our mailing list, please contact a member of the team.